FTH · Faeth Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Anand Kiran Parikh President and CEO | ▲ Buy | Option Exercise | 817,699 Shares held | 6/22/2026 | View profile |
| MILLENNIUM MANAGEMENT LLC 10% Owner | ▼ Sell | Open Market | 133,986 Shares held | 4/7/2026 | View profile |
| Cambrian BioPharma Inc 10% Owner | ▼ Sell | Open Market | 130,142 Shares held | 6/1/2026 | View profile |
| James Peyer Director | ▼ Sell | Open Market | 130,142 Shares held | 6/1/2026 | View profile |
| John Celebi President and CEO | ▼ Sell | Tax Withholding | 105,862 Shares held | 2/19/2025 | View profile |
| Colgan Erin Chief Financial Officer | ▼ Sell | Tax Withholding | 67,462 Shares held | 2/15/2024 | View profile |
| van der Horst Edward Chief Scientific Officer | ▼ Sell | Tax Withholding | 59,794 Shares held | 2/19/2025 | View profile |
| Brian C. Stephenson Chief Financial Officer | ▲ Buy | Open Market | 46,688 Shares held | 7/1/2026 | View profile |
| Stephen M. Hahn | ▼ Sell | Other | 44,763 Shares held | 6/15/2026 | View profile |
| Gallagher Patrick Stephen Chief Business Officer | ▲ Buy | Grant | 43,515 Shares held | 2/15/2023 | View profile |
| Holmen Bob Director | ▲ Buy | Grant | 25,598 Shares held | 7/10/2023 | View profile |
| RINGO WILLIAM R Director | ▲ Buy | Grant | 23,399 Shares held | 7/10/2023 | View profile |
| Pierce Robert Hamilton Chief R&D Officer | ▲ Buy | Grant | 21,000 Shares held | 2/15/2022 | View profile |
| Thomas G. Ricks Director | ▲ Buy | Grant | 8,932 Shares held | 7/10/2023 | View profile |
| Broder Samuel Director | ▲ Buy | Grant | 8,932 Shares held | 7/10/2023 | View profile |
| Humer Kristian Director | ▲ Buy | Grant | 8,932 Shares held | 7/10/2023 | View profile |
| English Jessie Director | ▲ Buy | Grant | 8,932 Shares held | 7/10/2023 | View profile |
| Vojta Deneen Director | ▲ Buy | Grant | 8,932 Shares held | 7/10/2023 | View profile |
| Apeiron Investment Group Ltd. 10% Owner | ▼ Sell | Open Market | 0 Shares held | 6/1/2023 | View profile |
Transaction History
| Brian C. Stephenson | ▲ Buy | Open Market | 4,400 | $103K | 7/1/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 600 | $15K | 7/1/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,910 | $44K | 6/30/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,638 | $39K | 6/30/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 4,255 | $106K | 6/30/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 831 | $19K | 6/29/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 580 | $14K | 6/26/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 4,212 | $105K | 6/26/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,358 | $35K | 6/26/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 100 | $3K | 6/26/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 2,891 | $73K | 6/24/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 3,000 | $78K | 6/24/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 3,400 | $92K | 6/24/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 100 | $3K | 6/24/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 6,836 | $165K | 6/23/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,969 | $49K | 6/23/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 425 | $11K | 6/23/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,797 | $36K | 6/22/2026 |
| Anand Kiran Parikh | ▲ Buy | Option Exercise | 45,252 | $52K | 6/22/2026 |
| Anand Kiran Parikh | ▲ Buy | Option Exercise | 8,213 | $10K | 6/22/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,118 | $23K | 6/22/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 1,583 | $35K | 6/22/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 3,329 | $77K | 6/22/2026 |
| Brian C. Stephenson | ▲ Buy | Open Market | 356 | $9K | 6/22/2026 |
| Anand Kiran Parikh | ▲ Buy | Open Market | 2,806 | $55K | 6/22/2026 |
| Anand Kiran Parikh | ▼ Sell | Other | 761,428 | — | 6/15/2026 |
| Stephen M. Hahn | ▼ Sell | Other | 44,763 | — | 6/15/2026 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 24,524 | $490K | 6/1/2026 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 476 | $10K | 6/1/2026 |
| James Peyer | ▼ Sell | Open Market | 24,524 | $490K | 6/1/2026 |
| James Peyer | ▼ Sell | Open Market | 476 | $10K | 6/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,108 | $37K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 2,115 | $61K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 205 | $6K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 4,423 | $139K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 300 | $10K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,108 | $37K | 4/7/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,104 | $34K | 4/6/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,214 | $38K | 4/6/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 45 | $1K | 4/6/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 26 | $870 | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,276 | $44K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 701 | $25K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 3,099 | $96K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,265 | $40K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,794 | $58K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 374 | $12K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,134 | $39K | 4/2/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 3,401 | $121K | 4/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,104 | $35K | 4/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 46 | $2K | 4/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,161 | $37K | 4/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,613 | $56K | 4/1/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 616 | $15K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,770 | $45K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,048 | $28K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 17 | $472 | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 186 | $6K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,957 | $62K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 411 | $13K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 191 | $5K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,251 | $31K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 57 | $2K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 5 | $142 | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 87 | $3K | 3/31/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 2,992 | $75K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 4,995 | $130K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,176 | $31K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 370 | $10K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 518 | $13K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 370 | $10K | 3/30/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 10,643 | $280K | 3/27/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 4,384 | $120K | 3/27/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 294 | $8K | 3/27/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 469 | $13K | 3/27/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 36 | $985 | 3/27/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 778 | $21K | 3/26/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,327 | $37K | 3/26/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 2,601 | $75K | 3/26/2026 |
| MILLENNIUM MANAGEMENT LLC | ▲ Buy | Open Market | 1,025 | $31K | 3/26/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 583 | $16K | 3/26/2026 |
| MILLENNIUM MANAGEMENT LLC | ▼ Sell | Open Market | 1,274 | $37K | 3/26/2026 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 3,105 | $27K | 12/9/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 2,666 | $21K | 12/9/2025 |
| Cambrian BioPharma Inc | ▲ Buy | Option Exercise | 395 | $3K | 12/9/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 395 | $3K | 12/9/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 446 | $4K | 12/9/2025 |
| James Peyer | ▼ Sell | Open Market | 2,666 | $21K | 12/9/2025 |
| James Peyer | ▲ Buy | Option Exercise | 395 | $3K | 12/9/2025 |
| James Peyer | ▼ Sell | Open Market | 395 | $3K | 12/9/2025 |
| James Peyer | ▼ Sell | Open Market | 446 | $4K | 12/9/2025 |
| James Peyer | ▼ Sell | Open Market | 3,105 | $27K | 12/8/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 14,508 | $165K | 12/5/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 1,745 | $21K | 12/5/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 42 | $553 | 12/5/2025 |
| James Peyer | ▼ Sell | Open Market | 14,508 | $165K | 12/5/2025 |
| James Peyer | ▼ Sell | Open Market | 1,745 | $21K | 12/5/2025 |
| James Peyer | ▼ Sell | Open Market | 42 | $553 | 12/5/2025 |
| Cambrian BioPharma Inc | ▼ Sell | Open Market | 5,000 | $45K | 12/4/2025 |
| James Peyer | ▼ Sell | Open Market | 5,000 | $45K | 12/4/2025 |
| John Celebi | ▼ Sell | Tax Withholding | 5,558 | $3K | 2/19/2025 |
| van der Horst Edward | ▼ Sell | Tax Withholding | 2,276 | $1K | 2/19/2025 |
| van der Horst Edward | ▼ Sell | Tax Withholding | 2,843 | $2K | 2/15/2024 |
| John Celebi | ▼ Sell | Tax Withholding | 5,891 | $5K | 2/15/2024 |
| Colgan Erin | ▼ Sell | Tax Withholding | 3,627 | $3K | 2/15/2024 |
| John Celebi | ▲ Buy | Open Market | 500 | $425 | 9/11/2023 |
| Cambrian BioPharma Inc | ▼ Sell | Other | 1,587,302 | $2.0M | 7/31/2023 |
| James Peyer | ▼ Sell | Other | 1,587,302 | $2.0M | 7/31/2023 |
| RINGO WILLIAM R | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Thomas G. Ricks | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Broder Samuel | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Humer Kristian | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| English Jessie | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Vojta Deneen | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Holmen Bob | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Cambrian BioPharma Inc | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| James Peyer | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 |
| Apeiron Investment Group Ltd. | ▼ Sell | Open Market | 2,485,923 | $3.9M | 6/1/2023 |
| Apeiron Investment Group Ltd. | ▼ Sell | Open Market | 955,738 | $1.5M | 6/1/2023 |
| Apeiron Investment Group Ltd. | ▲ Buy | Open Market | 1,100 | $2K | 2/23/2023 |
| Apeiron Investment Group Ltd. | ▲ Buy | Open Market | 1,100 | $2K | 2/23/2023 |
| Gallagher Patrick Stephen | ▼ Sell | Tax Withholding | 9,383 | $14K | 2/15/2023 |
| van der Horst Edward | ▼ Sell | Tax Withholding | 9,525 | $14K | 2/15/2023 |
| John Celebi | ▼ Sell | Tax Withholding | 20,492 | $31K | 2/15/2023 |
| van der Horst Edward | ▲ Buy | Grant | 23,565 | $0 | 2/15/2023 |
| van der Horst Edward | ▲ Buy | Grant | 17,700 | $0 | 2/15/2023 |
| Gallagher Patrick Stephen | ▲ Buy | Grant | 29,313 | $0 | 2/15/2023 |
| Gallagher Patrick Stephen | ▲ Buy | Grant | 14,200 | $0 | 2/15/2023 |
| Colgan Erin | ▲ Buy | Grant | 30,046 | $0 | 2/15/2023 |
| Colgan Erin | ▲ Buy | Grant | 21,300 | $0 | 2/15/2023 |
| John Celebi | ▲ Buy | Grant | 51,893 | $0 | 2/15/2023 |
| John Celebi | ▲ Buy | Grant | 21,300 | $0 | 2/15/2023 |
| Colgan Erin | ▼ Sell | Tax Withholding | 10,943 | $16K | 2/15/2023 |
| Cambrian BioPharma Inc | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| James Peyer | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| Vojta Deneen | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| English Jessie | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| Thomas G. Ricks | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| Humer Kristian | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| Broder Samuel | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| Holmen Bob | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 |
| RINGO WILLIAM R | ▲ Buy | Grant | 8,933 | $0 | 3/8/2022 |
| RINGO WILLIAM R | ▲ Buy | Grant | 10,000 | $0 | 3/8/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 1,203 | $4K | 3/2/2022 |
| James Peyer | ▲ Buy | Open Market | 1,203 | $4K | 3/2/2022 |
| James Peyer | ▲ Buy | Open Market | 2,458 | $9K | 3/1/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 2,458 | $9K | 3/1/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 42 | $151 | 2/28/2022 |
| James Peyer | ▲ Buy | Open Market | 42 | $151 | 2/28/2022 |
| James Peyer | ▲ Buy | Open Market | 2,500 | $9K | 2/25/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 2,500 | $9K | 2/25/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 15,000 | $54K | 2/24/2022 |
| James Peyer | ▲ Buy | Open Market | 15,000 | $54K | 2/24/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 2,500 | $10K | 2/23/2022 |
| James Peyer | ▲ Buy | Open Market | 2,500 | $10K | 2/23/2022 |
| James Peyer | ▲ Buy | Open Market | 15,000 | $60K | 2/18/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 15,000 | $60K | 2/18/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 4,949 | $21K | 2/17/2022 |
| James Peyer | ▲ Buy | Open Market | 4,949 | $21K | 2/17/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 2,551 | $11K | 2/16/2022 |
| James Peyer | ▲ Buy | Open Market | 2,551 | $11K | 2/16/2022 |
| Pierce Robert Hamilton | ▲ Buy | Grant | 21,000 | $0 | 2/15/2022 |
| John Celebi | ▲ Buy | Grant | 53,900 | $0 | 2/15/2022 |
| Colgan Erin | ▲ Buy | Grant | 21,000 | $0 | 2/15/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 10,000 | $42K | 2/14/2022 |
| James Peyer | ▲ Buy | Open Market | 10,000 | $42K | 2/14/2022 |
| James Peyer | ▲ Buy | Open Market | 12,500 | $55K | 2/11/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 12,500 | $55K | 2/11/2022 |
| James Peyer | ▲ Buy | Open Market | 5,000 | $23K | 2/10/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 5,000 | $23K | 2/10/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 10,000 | $43K | 2/8/2022 |
| James Peyer | ▲ Buy | Open Market | 10,000 | $43K | 2/8/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 2,500 | $11K | 2/4/2022 |
| James Peyer | ▲ Buy | Open Market | 2,500 | $11K | 2/4/2022 |
| James Peyer | ▲ Buy | Open Market | 17,500 | $81K | 2/3/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 17,500 | $81K | 2/3/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 8,900 | $38K | 1/28/2022 |
| James Peyer | ▲ Buy | Open Market | 8,900 | $38K | 1/28/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 6,100 | $26K | 1/27/2022 |
| James Peyer | ▲ Buy | Open Market | 6,100 | $26K | 1/27/2022 |
| James Peyer | ▲ Buy | Open Market | 29,900 | $138K | 1/26/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 29,900 | $138K | 1/26/2022 |
| James Peyer | ▲ Buy | Open Market | 20,100 | $98K | 1/25/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 20,100 | $98K | 1/25/2022 |
| James Peyer | ▲ Buy | Open Market | 22,707 | $106K | 1/24/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 22,707 | $106K | 1/24/2022 |
| James Peyer | ▲ Buy | Open Market | 24,703 | $122K | 1/21/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 24,703 | $122K | 1/21/2022 |
| James Peyer | ▲ Buy | Open Market | 20,000 | $103K | 1/20/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 20,000 | $103K | 1/20/2022 |
| James Peyer | ▲ Buy | Open Market | 10,244 | $51K | 1/19/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 10,244 | $51K | 1/19/2022 |
| James Peyer | ▲ Buy | Open Market | 10,000 | $51K | 1/18/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 10,000 | $51K | 1/18/2022 |
| James Peyer | ▲ Buy | Open Market | 6,219 | $31K | 1/14/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 6,219 | $31K | 1/14/2022 |
| James Peyer | ▲ Buy | Open Market | 19,953 | $102K | 1/13/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 19,953 | $102K | 1/13/2022 |
| James Peyer | ▲ Buy | Open Market | 9,202 | $48K | 1/12/2022 |
| Cambrian BioPharma Inc | ▲ Buy | Open Market | 9,202 | $48K | 1/12/2022 |